35.56
Indivior Plc stock is traded at $35.56, with a volume of 2.84M.
It is down -0.64% in the last 24 hours and up +18.14% over the past month.
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
See More
Previous Close:
$35.79
Open:
$36.3
24h Volume:
2.84M
Relative Volume:
1.32
Market Cap:
$4.45B
Revenue:
$1.12B
Net Income/Loss:
$5.00M
P/E Ratio:
3,556.00
EPS:
0.01
Net Cash Flow:
$-383.00M
1W Performance:
+1.25%
1M Performance:
+18.14%
6M Performance:
+155.28%
1Y Performance:
+209.22%
Indivior Plc Stock (INDV) Company Profile
Name
Indivior Plc
Sector
Phone
804-379-1090
Address
234 BATH ROAD, SLOUGH, BERKSHIRE
Compare INDV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
INDV
Indivior Plc
|
35.56 | 4.47B | 1.12B | 5.00M | -383.00M | 0.01 |
|
ZTS
Zoetis Inc
|
118.66 | 51.85B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.33 | 45.46B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.52 | 42.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.79 | 34.62B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
493.99 | 21.03B | 3.08B | 1.24B | 1.07B | 25.61 |
Indivior Plc Stock (INDV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-06-25 | Initiated | H.C. Wainwright | Buy |
| Jul-22-25 | Resumed | Jefferies | Buy |
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Jul-23-24 | Initiated | Piper Sandler | Overweight |
| Apr-03-24 | Initiated | Craig Hallum | Buy |
| Jul-13-23 | Initiated | Northland Capital | Outperform |
View All
Indivior Plc Stock (INDV) Latest News
Indivior (INDV) Is Up 8.9% After Newtyn Ups Stake And EBITDA Guidance RisesHas The Bull Case Changed? - Sahm
Indivior stock hits all-time high at 37.72 USD By Investing.com - Investing.com Canada
What drives Indivior PLC stock priceWeekly Market Snapshot & Double Or Triple Profits - earlytimes.in
Indivior stock hits all-time high at 37.72 USD - Investing.com
Why One Value Fund Has a $101 Million Bet on Indivior Stock Amid a 212% Surge - sharewise.com
What analysts say about Indivior PLC stockResistance Zone Identification & Big Gains Low Cost - earlytimes.in
Is Indivior PLC stock a dividend growth opportunity2025 Analyst Calls & Verified Entry Point Detection - Newser
Indivior PLC Stock Analysis and ForecastTrading Volume Surges & Low Risk Trading Ideas - earlytimes.in
Indivior Shares Move Above Key Trend Level - Kalkine Media
How Indivior PLC stock reacts to inflationary pressuresQuarterly Trade Review & Growth Focused Entry Reports - Newser
Can Indivior PLC stock weather global recessionJuly 2025 Weekly Recap & Advanced Swing Trade Entry Plans - Newser
Is Indivior PLC (2IVB) stock attractive post correctionJuly 2025 News Drivers & Real-Time Buy Signal Alerts - Newser
Can Indivior PLC stock sustain institutional interest2025 Historical Comparison & Long-Term Capital Growth Strategies - Newser
Indivior (INDV) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Is Indivior PLC a good long term investmentMarket Sentiment Indicators & Rapid Wealth Accumulation - earlytimes.in
Indivior Proposes New Corporate Structure to Achieve U.S. Domiciliation (PR Newswire) - Aktiellt
Clinical Evidence Supports Rapid SUBLOCADE® Induction as a Strategy to Improve Retention in Opioid Use Disorder Treatment (PR Newswire) - Aktiellt
Indivior PLC (INDV) Stock Price Today | Live Chart & News - Traders Union
Indivior stock hits all-time high of 33.72 USD By Investing.com - Investing.com Australia
Indivior stock hits all-time high of 33.72 USD - Investing.com
Piper Sandler Healthcare Conference - MarketScreener
INDVIndivior Latest Stock News & Market Updates - Stock Titan
Rodman & Renshaw sets $16 target on Indivior stock with Buy rating - MSN
Indivior PLC (INDV) Stock Price Prediction: Today, Tomorrow, Next Week - Traders Union
Indivior PLC (INDV) Stock Price Prediction for 2026, 2030-2040 - Traders Union
Indivior resolving legacy DOJ matter removes ‘major overhang,’ says Northland - MSN
Indivior price target raised to $41 from $27 at Piper Sandler - MSN
Indivior (INDV) Resolves Major Legal Issue, Outlook Remains Posi - GuruFocus
Indivior Concludes Legacy U.S. Department of Justice Matter - The Malaysian Reserve
Indivior Concludes DOJ Settlement with Final Payment - The Globe and Mail
Indivior pays $295 million to conclude legacy DOJ matter By Investing.com - Investing.com India
Can Indivior PLC (2IVB) stock sustain double digit ROEAnalyst Upgrade & Capital Efficient Trading Techniques - newser.com
Indivior (INDV) Is Up 6.5% After Settling DOJ Liability and Ending Resolution Agreement – Has The Bull Case Changed? - simplywall.st
How Indivior PLC stock valuations compare to rivalsNew Guidance & Accurate Buy Signal Notifications - newser.com
A Fresh Look at Indivior (INDV) Valuation Following Recent Share Price Surge - Yahoo Finance
Indivior concludes legacy U.S. Department of Justice matter - TipRanks
Indivior pays $295 million to conclude legacy DOJ matter - Investing.com
Indivior (INDV) Resolves DOJ Case with $295M Payment - GuruFocus
Will Indivior PLC (2IVB) stock draw ESG focused fundsWeekly Volume Report & AI Driven Price Predictions - newser.com
Indivior to Participate in the Piper Sandler 37th Annual Healthcare Conference - BioSpace
Leading vs lagging indicators on Indivior PLC performance2025 Price Momentum & Short-Term Swing Trade Alerts - newser.com
Why analysts maintain buy rating on Indivior PLC (2IVB) stock2025 Technical Patterns & AI Driven Price Predictions - newser.com
Indivior Plc Stock (INDV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):